85 related articles for article (PubMed ID: 3481028)
21. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
Nichols GE; Normansell DE; Williams ME
Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
23. [Cellular and molecular biology of malignant lymphoma].
Tesch H; Stein H; Diehl V
Internist (Berl); 1993 Feb; 34(2):89-96. PubMed ID: 8454437
[No Abstract] [Full Text] [Related]
24. [Molecular cytogenetic approach on malignant lymphoma].
Funato T
Rinsho Byori; 1994 Jul; 42(7):682-8. PubMed ID: 8065032
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetics of lymphomas.
Campbell LJ
Pathology; 2005 Dec; 37(6):493-507. PubMed ID: 16373229
[TBL] [Abstract][Full Text] [Related]
26. Nonrandom chromosome abnormalities in lymphoma.
Bloomfield CD; Arthur DC; Frizzera G; Levine EG; Peterson BA; Gajl-Peczalska KJ
Cancer Res; 1983 Jun; 43(6):2975-84. PubMed ID: 6850608
[TBL] [Abstract][Full Text] [Related]
27. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
[TBL] [Abstract][Full Text] [Related]
28. AIDS primary central nervous system lymphoma: molecular analysis of the expressed VH genes and possible implications for lymphomagenesis.
Julien S; Radosavljevic M; Labouret N; Camilleri-Broet S; Davi F; Raphael M; Martin T; Pasquali JL
J Immunol; 1999 Feb; 162(3):1551-8. PubMed ID: 9973412
[TBL] [Abstract][Full Text] [Related]
29. [Molecular biology in malignant blood diseases. Clinical applications. Study of immunoglobulin and T-cell receptor genes and molecular analysis of the translocations].
González M; García-Sanz R; Vargas M; Balanzategui A; Chillón MC; Mateos MV; San Miguel JF
Sangre (Barc); 1996 Aug; 41(4):321-34. PubMed ID: 8984674
[No Abstract] [Full Text] [Related]
30. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
31. Polymerase chain reaction in the assessment of lymphomas.
Diss TC; Pan L
Cancer Surv; 1997; 30():21-44. PubMed ID: 9547984
[TBL] [Abstract][Full Text] [Related]
32. Lymphomas involving the eye and the ocular adnexa.
Coupland SE; Damato B
Curr Opin Ophthalmol; 2006 Dec; 17(6):523-31. PubMed ID: 17065920
[TBL] [Abstract][Full Text] [Related]
33. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified.
Ishida T; Inagaki H; Utsunomiya A; Takatsuka Y; Komatsu H; Iida S; Takeuchi G; Eimoto T; Nakamura S; Ueda R
Clin Cancer Res; 2004 Aug; 10(16):5494-500. PubMed ID: 15328188
[TBL] [Abstract][Full Text] [Related]
34. [Clinical use of polymerase chain reaction in diagnosis and monitoring of malignant diseases].
Jäger U; Laczika K; Scholten C; Mitterbauer M; Novak M; Lechner K
Wien Klin Wochenschr; 1996; 108(20):634-9. PubMed ID: 9005678
[TBL] [Abstract][Full Text] [Related]
35. Orbital marginal zone lymphomas: an immunohistochemical, polymerase chain reaction, and fluorescence in situ hybridization study.
Schiby G; Polak-Charcon S; Mardoukh C; Rosenblatt K; Goldberg I; Kneller A; Rosner M; Kopolovic J
Hum Pathol; 2007 Mar; 38(3):435-42. PubMed ID: 17217996
[TBL] [Abstract][Full Text] [Related]
36. T-cell receptor gene analysis in cutaneous T-cell lymphomas.
Whittaker S
Clin Exp Dermatol; 1996 Mar; 21(2):81-7. PubMed ID: 8759190
[TBL] [Abstract][Full Text] [Related]
37. [Semiquantitative monitoring of molecular markers in non-Hodgkin's lymphoma].
Slavícková A; Benesová E; Bradová V; Ullmanová V
Cas Lek Cesk; 1997 Apr; 136(7):221-5. PubMed ID: 9221198
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of chromosome aberrations in hematological malignancies. Southern hybridization.
Saltman DL; Hunger SP; Turner GE
Methods Mol Biol; 1994; 29():437-48. PubMed ID: 8032421
[No Abstract] [Full Text] [Related]
39. AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas.
Mucenski ML; Taylor BA; Jenkins NA; Copeland NG
Mol Cell Biol; 1986 Dec; 6(12):4236-43. PubMed ID: 3025647
[TBL] [Abstract][Full Text] [Related]
40. The molecular pathology of lymphomas.
Kirsch IR; Broder S
J Clin Oncol; 1986 Mar; 4(3):271-4. PubMed ID: 3950671
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
